ZERIA PHARMACEUTICAL CO.,LTD. 4559Short Interest

No institution currently reports a short position of 0.5% or more in ZERIA PHARMACEUTICAL CO.,LTD. (4559). The last disclosure was on 2025-09-29 (Nomura International plc, 0.49%).

Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
18 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 4 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2019-08-05
Latest disclosure2025-09-29 (Nomura International plc, 0.49%)
Reporting institutions4 firms (18 reports)
Peak estimated short interest0.71% (2021-04-13, 1 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • スパークス・アセット・マネジメント株式会社
  • Nomura International plc
  • Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2019-10-08 Morgan Stanley MUFG Securities Co., Ltd. Position 262,124 shares Ratio 0.49% ▼0.01% −6,800 Below 0.5%
2025-09-29 Nomura International plc Position 258,640 shares Ratio 0.49% ▼0.02% −17,290 Below 0.5%
2022-09-29 スパークス・アセット・マネジメント株式会社 Position 257,900 shares Ratio 0.48% ▼0.11% −60,800 Below 0.5%
2022-10-28 Integrated Core Strategies (Asia) Pte. Ltd. Position 13,600 shares Ratio 0.02% ▼0.48% −255,916 Below 0.5%

Disclosure History 18 in total

Trade date Short seller Position (shares) Ratio Change Note
2025-09-29 Nomura International plc Position 258,640 shares Ratio 0.49% ▼0.02% −17,290 Below 0.5%
2025-08-06 Nomura International plc Position 275,930 shares Ratio 0.51% ▲0.11% +78,333 —
2025-06-20 Nomura International plc Position 197,597 shares Ratio 0.37% ▼0.13% −68,877 Below 0.5%
2025-06-17 Nomura International plc Position 266,474 shares Ratio 0.50% ▲0.09% —
2022-10-28 Integrated Core Strategies (Asia) Pte. Ltd. Position 13,600 shares Ratio 0.02% ▼0.48% −255,916 Below 0.5%
2022-10-26 Integrated Core Strategies (Asia) Pte. Ltd. Position 269,516 shares Ratio 0.50% ▲0.10% —
2022-09-29 スパークス・アセット・マネジメント株式会社 Position 257,900 shares Ratio 0.48% ▼0.11% −60,800 Below 0.5%
2022-08-04 スパークス・アセット・マネジメント株式会社 Position 318,700 shares Ratio 0.59% ▼0.10% −49,100 —
2022-07-01 スパークス・アセット・マネジメント株式会社 Position 367,800 shares Ratio 0.69% ▼0.02% −12,600 —
2021-04-13 スパークス・アセット・マネジメント株式会社 Position 380,400 shares Ratio 0.71% ▲0.11% +57,400 —
2021-03-18 スパークス・アセット・マネジメント株式会社 Position 323,000 shares Ratio 0.60% ▲0.10% +54,600 —
2020-09-28 スパークス・アセット・マネジメント株式会社 Position 268,400 shares Ratio 0.50% ▲0.07% —
2019-10-08 Morgan Stanley MUFG Securities Co., Ltd. Position 262,124 shares Ratio 0.49% ▼0.01% −6,800 Below 0.5%
2019-09-18 Morgan Stanley MUFG Securities Co., Ltd. Position 268,924 shares Ratio 0.50% ▲0.01% +5,500 —
2019-09-12 Morgan Stanley MUFG Securities Co., Ltd. Position 263,424 shares Ratio 0.49% ▼0.09% −46,500 Below 0.5%
2019-08-22 Morgan Stanley MUFG Securities Co., Ltd. Position 309,924 shares Ratio 0.58% ▼0.02% −10,500 —
2019-08-08 Morgan Stanley MUFG Securities Co., Ltd. Position 320,424 shares Ratio 0.60% ▲0.08% +41,100 —
2019-08-05 Morgan Stanley MUFG Securities Co., Ltd. Position 279,324 shares Ratio 0.52% ▲0.10% —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
EIKEN CHEMICAL CO.,LTD.4549 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
JCR Pharmaceuticals Co.,Ltd.4552 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
TOWA PHARMACEUTICAL CO.,LTD.4553 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
Fuji Pharma Co.,Ltd.4554 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
CHUKYO IYAKUHIN CO.,LTD.4558 Standard Market(Domestic) Pharmaceutical Pharmaceutical
AnGes,Inc.4563 Growth Market(Domestic) Pharmaceutical Pharmaceutical
OncoTherapy Science,Inc.4564 Growth Market(Domestic) Pharmaceutical Pharmaceutical
Nxera Pharma Co.,Ltd.4565 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
DAIICHI SANKYO COMPANY,LIMITED4568 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Core30
KYORIN Pharmaceutical Co.,Ltd.4569 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1